Nasdaq

Sana Biotechnology Reports Promising Six-Month Results from First-in-Human Study on Hypoimmune-Modified Pancreatic Islet Cell Transplant for Type 1 Diabetes

Sana Biotechnology reports six-month results from a first-in-human study demonstrating safe pancreatic islet cell transplantation for type 1 diabetes without immunosuppression. Sana Biotechnology ...
National Academies of Sciences%2c Engineering%2c and Medicine

Interactions of Biotechnology with Human Physiology and Function – A Workshop

The ongoing biotechnological revolution, aided by advances in engineering and the computing and information sciences, has brought about a new generation of biotechnologies that interact with the human ...
MIT Technology Review

“Spare” living human bodies might provide us with organs for transplantation

But will these “bodyoids” ever be ethically acceptable? This week, MIT Technology Review published a piece on bodyoids—living bodies that cannot think or feel pain. In the piece, a trio of experts ...
PharmiWeb

VoxCell appoints Chief Commercial Officer as Demand Grows for Predictive, Human-Relevant, Non-Clinical Testing Approaches

VoxCell appoints Chief Commercial Officer as Demand Grows for Predictive, Human-Relevant, Non-Clinical Testing ...
Seeking Alpha

Sana Biotechnology Announces Publication in Nature Biotechnology of in vivo Gene Editing of Human Hematopoietic Stem Cells in Preclinical Models Using the Fusogen Platform

Data Demonstrate Potent in vivo Gene Editing of Hematopoietic Stem Cells (HSCs) in the Bone Marrow with Systemic Delivery in Preclinical Murine Models Using Fusogen Technology Broadens Application of ...

Human Liver Model Market Size to Reach USD 3.50 Billion by 2033, Driven by Rising Demand for Predictive Drug Testing – SNS Insider

According to SNS Insider, Human Liver Model Market growth is driven by Advances in 3D cell culture, liver-on-chip platforms, and growing focus on drug safety and disease modeling.Austin, Texas, Jan.